SPLICEBIO S.L.
A Healthtech startup included in the Barcelona & Catalonia Startup Hub

SPLICE BIO

SPLICEBIO S.L.
Carrer Baldiri Reixac, 10-12, (Parc Científic Barcelona) 08028 Barcelona
http://www.proteodesign.es
Biotech spin-out from princeton university focused on developing the next-gen cancer immunotherapy and targeted therapies. our proprietary technology enables precise targeting of dendritic cells in vivo to trigger an innate and adaptive response against cancer.
Industries & Technologies
Financial data
Other information
Funding
50M € (February 2022)
Minority stake unknown %
Investors: UCE Ventures, Ysios Capital, New Enterprise Associates (NEA), Gilde Healthcare, Novartis Venture Fund, Sabadell Asabys
1.7M € (March 2018)
Minority stake unknown %
Investors: CAIXA CAPITAL RISC, PRIVATE BUSINESS ANGEL
Source: Press releases newsletters & platforms company websites annual reports & accounts regulatory body sites & stock exchanges
@ProteoDesignHQ
Other startups near startup SPLICE BIO
similar companies

- Healthtech
- Omic Sciences
- New biological design
- Bioengineering & Regenerative medicine
- Deeptech

- Healthtech
- Omic Sciences
- New biological design
- Bioengineering & Regenerative medicine
- Industry 4.0
- Social Economy
- Deeptech
Collaborators.
We teamed up with business associations, universities and startup incubators to create the Barcelona & Catalonia Startup Hub.